Efficacy and Safety of DHEA for Myotonic Dystrophy
NCT00167609
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Myotonic Dystrophy
Interventions
DRUG:
dehydroepiandrosterone 100 and 400 mg
Sponsor
University of Versailles
Collaborators
[object Object]
[object Object]